CN Patent

CN101591332A — 基于4-苯基-6-(2,2,2-三氟-1-苯基乙氧基)嘧啶的化合物及其应用方法

Assigned to Desselay Biomedical Co Ltd · Expires 2009-12-02 · 16y expired

What this patent protects

本发明公开了式I化合物，以及包含它们的组合物，以及它们用于治疗、预防和/或管理疾病或紊乱的方法。

USPTO Abstract

本发明公开了式I化合物，以及包含它们的组合物，以及它们用于治疗、预防和/或管理疾病或紊乱的方法。

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: CN101591332A
Jurisdiction: CN
Classification: —
Expires: 2009-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Desselay Biomedical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.